Dr. Epstein Named America’s Top Optometrist by Newsweek
Newsweek’s ranking of America’s Best Eye Doctors 2021 was released July 22, and it named Arthur B. Epstein, OD, Phoenix Eye Care, and chief medical editor of Optometric Physician, the No. 1 optometrist in the country, with a score of 92.6%. Shannon L. Steinhäuser, OD, also of Phoenix Eye Care, and Epstein’s wife, was ranked No. 9, with a score of 89.1%. The publication looked at the 20 most populous states in the US and selected the 300 best optometrists and ophthalmologists, in a separate ranking. Researchers began with a survey of more than 10,000 optometrists, ophthalmologists, clinic managers and other healthcare professionals. “What we were looking for were the doctors who had earned the most respect from their peers in three categories: the quality of care they provide, the continuity of care and the quality of the technology they use in their practices,” wrote Nancy Cooper, Newsweek Global Editor in Chief. View the list.
B+L to Present 14 Scientific Posters at ASCRS Annual Meeting
Bausch + Lomb announced the presentation of 14 scientific posters involving the company’s ophthalmic surgical technologies at the American Society of Cataract and Refractive Surgery annual meeting, July 23-27 in Las Vegas. Ten presentations will discuss the clinical performance of one or more of the company’s enVista, Crystalens and Trulign intraocular lens platforms. Two posters will highlight the results of studies in which investigators used the cloud-based eyeTELLIGENCE clinical decision support software, available exclusively on the Stellaris Elite vision enhancement system, to evaluate energy and fluidics metrics and analyze the impact of COVID-19 on ophthalmic surgeries. View the schedule of presentations.
J&J Vision to Present Data on Latest Cataract Innovations at ASCRS Annual Meeting
Johnson & Johnson Vision announced that 21 company-sponsored studies supporting cataract surgery outcomes will be presented at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting. A complete listing of abstracts related to Johnson & Johnson Vision can be found on the ASCRS website. Read more.
Allergan to Present Data from Eye Care Portfolio at ASCRS Annual Meeting
Allergan will present new data from its portfolio of eye care medicines at the American Society for Cataract and Refractive Surgery Annual Meeting. Presentations will include new data on AGN-190584 (pilocarpine 1.25%), an investigational presbyopia treatment, and updated analyses on Durysta (bimatoprost intracameral implant). View the schedule of presentations.
Alcon to Present 70 Abstracts at ASCRS Annual Meeting
Alcon announced it would have approximately 70 abstracts highlighting the benefits of the Alcon cataract and refractive suite at the American Society for Cataract and Refractive Surgery Annual Meeting. A few highlights of the company’s data include: a high level of patient satisfaction and increased spectacle independence with PanOptix and Vivity; the ARGOS Biometer with Image Guidance delivered substantial time efficiencies for cataract surgery practices, surgeons and patients; and the NGENUITY 3D Visualization System Heads-Up Display increasing surgical ergonomics. Learn more.
Allegro Ophthalmics to Present Results of ALG-1007 Ex-U.S. Phase II Trial at ASCRS Annual Meeting
Allegro Ophthalmics announced the results of the company’s second ALG-1007 ex-U.S. clinical trial for the treatment of dry eye disease will be presented during the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting. On July 22, Allegro President and CEO Vicken Karageozian, MD, will present at Eyecelerator during its “Dry Eye: The Need for Innovation” session. On July 24, Eric D. Donnenfeld, MD, will present full study results of the company’s second ALG-1007 ex-U.S. clinical trial for DED. View the schedule of presentations.
NovaBay Partners with ImprimisRx to Promote Prescription Avenova
In addition, NovaBay Pharmaceuticals, a pharmaceutical company focusing on commercializing Avenova for the eye care market, is partnering with ImprimisRx, a wholly owned subsidiary of Harrow Health, to promote prescription Avenova. ImprimisRx will provide NovaBay with national sales, marketing and distribution support for its FDA-cleared 0.01% hypochlorous acid Avenova in 40 ml bottles. Avenova is a clinically proven antimicrobial lid and lash solution for the management of numerous chronic eye conditions. Read more.
Nanodropper & Unite For Sight Announce Global Health Partnership
Nanodropper is joining forces with Unite For Sight to launch a global health initiative aimed at providing better access to vision-saving medications in Ghana. The initiative will allow the public to donate Nanodroppers to Unite For Sight partner clinics in Ghana at $9 per adaptor, a substantially lower price than retail value. The Nanodropper easily twists on to eyedrop bottles and reduces the waste from a typical eyedrop. Learn more.
Surface Ophthalmics Announces $25 Million Private Round of Fundraising
Surface Ophthalmics secured gross proceeds of approximately $25 million in a private placement of preferred stock. The proceeds from this round of capital raising will be used to complete the ongoing Phase II clinical trial of SURF-100, an innovative head-to-head study comparing SURF-100 against leading on-market competitors lifitegrast ophthalmic solution 5% and cyclosporine ophthalmic emulsion 0.05% along with the Phase II clinical trial of SURF-200, being studied as a potential treatment for acute dry eye disease. Read more.